We recognize that CRP is a nonspecific marker of inflammation and can be influenced by factors beyond cancer, such as chronic obstructive pulmonary disease (COPD), bronchiectasis, autoimmune diseases, and smoking—all of which are prevalent in our patient population and particularly in men. This evidence concerns the gene CRP and cancer.